4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-24-006925
CVP, Chief Financial Officer sold 5,625 shares at an average $87.51 ($492,258)
- CVP, Chief Financial Officer acquired 5,625 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ullem Scott B. · CVP, Chief Financial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-06-20 | Exercise or conversion : show line 1 in the form 10b5-1 | +5,625 | $45.28 | $254,681 | 36,186 | D |
| 2024-06-20 | Sale : show line 2 in the form 10b5-1 | −400 | $88.11 | $35,245 | 35,786 | D |
| 2024-06-20 | Sale : show line 3 in the form 10b5-1 | −5,225 | $87.47 | $457,013 | 30,561 | D |
| Open-market sales · 5,625 sh · avg $87.51 · $492,258 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-06-20 | Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −5,625 | 56,250 | D |
Loading xslF345X05/doc4.xml…